These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 323074)

  • 21. [Our experience with the use of the contraceptive preparations Femovan and Triquilar from the Schering firm].
    Milchev N; Terzhumanov R; Grozdanov G; Krumov G
    Akush Ginekol (Sofiia); 1992; 31(2):42-3. PubMed ID: 1342561
    [No Abstract]   [Full Text] [Related]  

  • 22. Fertility regulation using "triphasic" administration of ethinyl estradiol and levonorgestrel in comparison with the 30 plus 150 micrograms fixed dose regime.
    Zador G
    Acta Obstet Gynecol Scand Suppl; 1979; 88():43-8. PubMed ID: 393049
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral contraception, 1986. Focus on Triphasil.
    Ellsworth H
    J Reprod Med; 1986 Jun; 31(6 Suppl):559-64. PubMed ID: 3522896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of a multicentre trial of a new low-dose oral contraceptive in Great Britain.
    Bye PG
    Acta Obstet Gynecol Scand Suppl; 1976; 54():61-6. PubMed ID: 788447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent.
    Yuzpe AA; Smith RP; Rademaker AW
    Fertil Steril; 1982 Apr; 37(4):508-13. PubMed ID: 7040117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical assessment of a low-oestrogen combined oral contraceptive.
    Bye PG; Elstein M
    Br Med J; 1973 May; 2(5863):389-92. PubMed ID: 4574044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive.
    Woutersz TB; Korba VD
    Int J Fertil; 1988; 33(6):406-10. PubMed ID: 2906915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of Ovidon, Rigevidon and Postinor for contraception].
    Kulakov VI; Barinov AM; Prilepskaia VN
    Akush Ginekol (Mosk); 1983 Nov; (11):22-4. PubMed ID: 6666791
    [No Abstract]   [Full Text] [Related]  

  • 30. Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding.
    Davis A; Godwin A; Lippman J; Olson W; Kafrissen M
    Obstet Gynecol; 2000 Dec; 96(6):913-20. PubMed ID: 11084177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical use of norgestrel-ethinyl oestradiol as a contraceptive.
    Tyler ET; Matsner EM; Gotlib MH; Levin M; Daniels T; Shimabukuro B; Dolman H; Elliot J
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:109-16. PubMed ID: 5288229
    [No Abstract]   [Full Text] [Related]  

  • 32. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Low dose p-pills, Gynatrol and Mikrogyn].
    Falck Larsen J
    Ugeskr Laeger; 1976 Sep; 138(40):2446-7. PubMed ID: 969002
    [No Abstract]   [Full Text] [Related]  

  • 34. [Emergency contraception ].
    Amaliev G
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():19-24. PubMed ID: 19504703
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-oestrogen combined oral contraceptive.
    Foss GL; Fotherby K
    Acta Eur Fertil; 1973 Jun; 4(2):57-8. PubMed ID: 4784140
    [No Abstract]   [Full Text] [Related]  

  • 37. Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo.
    Cullberg J
    Acta Psychiatr Scand Suppl; 1972; 236():1-86. PubMed ID: 4565340
    [No Abstract]   [Full Text] [Related]  

  • 38. Profile of a new low dose combination estrogen and progestogen oral contraceptive: a review of nine clinical studies.
    Woutersz TB
    J Reprod Med; 1975 Sep; 15(3):87-92. PubMed ID: 1214254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol.
    Goldzieher JW
    J Reprod Med; 1983 Jan; 28(1 Suppl):53-6. PubMed ID: 6403700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum activity of lysosomal enzymes in relationship to contraceptive steroid dose.
    Briggs MH; Briggs M
    Curr Med Res Opin; 1975; 3(4):203-5. PubMed ID: 1149488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.